Investors & Media

Press Releases



All Releases
View Summary TG Therapeutics, Inc. Announces Second Quarter 2014 Financial Results and Business Update
Jul 21, 2014
PDF 117.0 KB Add to Briefcase
View Summary TG Therapeutics Completes Global Licensing Agreement With Ligand Pharmaceuticals for the Development of Inhibitors of IRAK4
Jun 24, 2014
PDF 109.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 2014 JMP Securities Healthcare Conference
Jun 23, 2014
PDF 105.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 2014 Wells Fargo Healthcare Conference
Jun 16, 2014
PDF 105.8 KB Add to Briefcase
View Summary TG Therapeutics' TG-1101 (Ublituximab) in Combination With Ibrutinib Demonstrates Compelling Clinical Activity and Safety Profile in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)
Jun 13, 2014
PDF 159.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Presentation of Single Agent Data for Both TG-1101 and TGR-1202 in Ongoing Phase I Clinical Studies
May 30, 2014
PDF 201.3 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Clinical Data Presentations for TG-1101 and TGR-1202 at the European Hematology Association (EHA) Meeting in Milan, Italy
May 22, 2014
PDF 111.7 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces First Quarter 2014 Financial Results and Business Update
May 12, 2014
PDF 115.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Host Conference Call on First Quarter 2014 Financial Results and Business Update
May 9, 2014
PDF 106.4 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Provides Update on a Modified TGR-1202 Formulation and Fed-State Dosing With Data Demonstrating Significantly Higher TGR-1202 Exposure
May 8, 2014
PDF 109.7 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Clinical Data Presentations at Upcoming Conferences
May 6, 2014
PDF 111.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 39th Annual Deutsche Bank Healthcare Conference
May 5, 2014
PDF 105.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Preclinical Poster Presentations for TGR-1202 at AACR 2014
Apr 7, 2014
PDF 147.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces $18.1 Million Underwritten Sale of Common Stock to a Single Institutional Investor
Mar 11, 2014
PDF 109.7 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 26th Annual ROTH Conference
Mar 10, 2014
PDF 105.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results and Business Update
Mar 5, 2014
PDF 118.9 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2013 Financial Results and Business Update
Mar 4, 2014
PDF 106.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 16th Annual BIO CEO & Investor Conference
Feb 7, 2014
PDF 13.8 KB Add to Briefcase
View Summary TG Therapeutics, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 13, 2014
PDF 15.4 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Presentation of Encouraging Clinical Activity of TGR-1202 in an Ongoing Multi-Center Phase I Clinical Study
Dec 9, 2013
PDF 114.8 KB Add to Briefcase
Showing 161-180 of 228 Page: 1 ... 5 6 7 8 9 10 11 12  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase